메뉴 건너뛰기




Volumn 370, Issue 5, 2014, Pages 412-420

Romosozumab in postmenopausal women with low bone mineral density

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; PARATHYROID HORMONE[1-34]; PLACEBO; ROMOSOZUMAB;

EID: 84893044528     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1305224     Document Type: Article
Times cited : (934)

References (16)
  • 1
    • 0035857351 scopus 로고    scopus 로고
    • NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy
    • NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001;285: 785-95.
    • (2001) JAMA , vol.285 , pp. 785-795
  • 4
    • 78650646959 scopus 로고    scopus 로고
    • Distinct modes of inhibition by sclerostin on bone morphogenetic protein and Wnt signaling pathways
    • Krause C, Korchynskyi O, de Rooij K, et al. Distinct modes of inhibition by sclerostin on bone morphogenetic protein and Wnt signaling pathways. J Biol Chem 2010;285:41614-26.
    • (2010) J Biol Chem , vol.285 , pp. 41614-41626
    • Krause, C.1    Korchynskyi, O.2    De Rooij, K.3
  • 5
    • 34250823973 scopus 로고    scopus 로고
    • Minireview: Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton
    • DOI 10.1210/en.2007-0270
    • Baron R, Rawadi G. Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton. Endocrinology 2007;148:2635-43. (Pubitemid 46984775)
    • (2007) Endocrinology , vol.148 , Issue.6 , pp. 2635-2643
    • Baron, R.1    Rawadi, G.2
  • 9
    • 65549152230 scopus 로고    scopus 로고
    • Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of post-menopausal osteoporosis
    • Li X, Ominsky MS, Warmington KS, et al. Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of post-menopausal osteoporosis. J Bone Miner Res 2009;24:578-88.
    • (2009) J Bone Miner Res , vol.24 , pp. 578-588
    • Li, X.1    Ominsky, M.S.2    Warmington, K.S.3
  • 10
    • 77953481395 scopus 로고    scopus 로고
    • Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength
    • Ominsky MS, Vlasseros F, Jolette J, et al. Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength. J Bone Miner Res 2010;25: 948-59.
    • (2010) J Bone Miner Res , vol.25 , pp. 948-959
    • Ominsky, M.S.1    Vlasseros, F.2    Jolette, J.3
  • 11
    • 84868290353 scopus 로고    scopus 로고
    • Sclerostin and Dickkopf-1 as therapeutic targets in bone diseases
    • Ke HZ, Richards WG, Li X, Ominsky MS. Sclerostin and Dickkopf-1 as therapeutic targets in bone diseases. Endocr Rev 2012;33:747-83.
    • (2012) Endocr Rev , vol.33 , pp. 747-783
    • Ke, H.Z.1    Richards, W.G.2    Li, X.3    Ominsky, M.S.4
  • 12
    • 84873558051 scopus 로고    scopus 로고
    • WNT signaling in bone homeostasis and disease: From human mutations to treatments
    • Baron R, Kneissel M. WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med 2013;19:179-92.
    • (2013) Nat Med , vol.19 , pp. 179-192
    • Baron, R.1    Kneissel, M.2
  • 13
    • 78650958526 scopus 로고    scopus 로고
    • Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody
    • Padhi D, Jang G, Stouch B, Fang L, Posvar E. Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody. J Bone Miner Res 2011;26:19-26.
    • (2011) J Bone Miner Res , vol.26 , pp. 19-26
    • Padhi, D.1    Jang, G.2    Stouch, B.3    Fang, L.4    Posvar, E.5
  • 14
    • 0033574249 scopus 로고    scopus 로고
    • A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation
    • Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999;130:461-70. (Pubitemid 29135798)
    • (1999) Annals of Internal Medicine , vol.130 , Issue.6 , pp. 461-470
    • Levey, A.S.1    Bosch, J.P.2    Lewis, J.B.3    Greene, T.4    Rogers, N.5    Roth, D.6
  • 16
    • 81855180504 scopus 로고    scopus 로고
    • Patients with sclerosteosis and disease carriers: Human models of the effect of sclerostin on bone turnover
    • van Lierop AH, Hamdy NA, Hamersma H, et al. Patients with sclerosteosis and disease carriers: human models of the effect of sclerostin on bone turnover. J Bone Miner Res 2011;26:2804-11.
    • (2011) J Bone Miner Res , vol.26 , pp. 2804-2811
    • Van Lierop, A.H.1    Hamdy, N.A.2    Hamersma, H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.